ENvizion Medical Ltd.
ENVM.TA
Tel Aviv Stock Exchange54.00
ILA
+3.40
- -
ENvizion Medical Ltd.
ENVM.TA
(Tel Aviv Stock Exchange)
Recent
price
54.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- ENvizion Medical Ltd. (ENVM.TA) develops and commercializes advanced medical devices focused on enteral feeding tube navigation and placement to prevent malnutrition and reduce complications in critically ill patients. The company offers its flagship ENvue system, an FDA 510(k)-cleared electromagnetic navigation platform comprising an electro-mechanical device with embedded software and compatible enteral feeding tubes; this technology provides real-time, multi-view (frontal, lateral, and axial) visualization of patient body contours for precise tube guidance into the stomach or small intestine via oral or nasoenteric routes, minimizing lung misplacement risks, procedure times, radiation exposure, and healthcare costs. ENvizion targets hospitals, ICUs, and critical care units serving mechanically ventilated, post-surgical, or premature patients requiring immediate nutrition. In July 2024, Alpha Capital Anstalt acquired all operating assets and intellectual property of ENvizion Medical Ltd., including its U.S. subsidiary ENvizion Medical Inc., transitioning the primary operations to a privately held entity independent of the former publicly traded parent. The former parent company, ENvizion Medical Ltd., changed its name to Hodayat Haaretz Ltd. in November 2024. These changes support accelerated U.S. healthcare market expansion, building on prior adoption in numerous U.S. hospitals and a 2020 partnership with one of the largest private U.S. hospital chains for deployment across 150 facilities. Founded in 2019 and previously headquartered in Israel with U.S. operations based in Arlington Heights, Illinois, ENvizion operates primarily in the medtech segment of enteral nutrition, with products utilized worldwide but emphasizing North American hospital networks.